Hunan Fangsheng Pharmaceutical Co., Ltd.
SHH: 603998.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xiaoli Zhou
- Employees
- 1,686
- Headquarters
- Changsha, China
- IPO year
- 2014
- Market cap
- CN¥4.8B
- Website
- https://www.fangsheng.com.cn
Loading 603998…
Loading profile data…Frequently asked questions about 603998
What does Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS) do?
Hunan Fangsheng Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for cardiovascular and cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infectives. The company was founded in 2002 and is based in...
Where does 603998.SS trade?
Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS) trades on the Shanghai Stock Exchange.
What sector is 603998.SS in?
Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hunan Fangsheng Pharmaceutical Co., Ltd.?
Xiaoli Zhou is the chief executive officer of Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS).
Where is Hunan Fangsheng Pharmaceutical Co., Ltd. headquartered?
Hunan Fangsheng Pharmaceutical Co., Ltd. is headquartered in China.
Does 603998.SS pay a dividend?
Yes — Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS) paid a trailing twelve-month dividend of CNY 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603998.SS go public?
Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS) completed its initial public offering in 2014.